Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein. - Wikidata - wikimedia - TriplyDB

Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein.

Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein.

http://www.wikidata.org/entity/Q34712578

about

HTLV-1 Tax mediated downregulation of miRNAs associated with chromatin remodeling factors in T cells with stably integrated viral promoter Retinoic acid induces HL-60 cell differentiation via the upregulation of miR-663 MicroRNA-137 promoter methylation in oral rinses from patients with squamous cell carcinoma of the head and neck is associated with gender and body mass index Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia Expression and function of micro-RNAs in immune cells during normal or disease state Emerging Roles for MicroRNAs in Perioperative Medicine DNA methylation and microRNAs in cancer Tumor suppressor microRNAs: a novel non-coding alliance against cancer Progress and challenge of microRNA research in immunity MicroRNA-regulated pathways in hematological malignancies: how to avoid cells playing out of tune The prognostic and functional role of microRNAs in acute myeloid leukemia MicroRNA: basic mechanisms and transcriptional regulatory networks for cell fate determination Lung cancer epigenetics: emerging biomarkers MicroRNAs distinguish cytogenetic subgroups in pediatric AML and contribute to complex regulatory networks in AML-relevant pathways MicroRNA-223 is neuroprotective by targeting glutamate receptors.Novel RNA-binding properties of the MTG chromatin regulatory proteins.Mir-223 regulates the number and function of myeloid-derived suppressor cells in multiple sclerosis and experimental autoimmune encephalomyelitis.MicroRNAs: critical mediators of differentiation, development and disease.PRMT4 blocks myeloid differentiation by assembling a methyl-RUNX1-dependent repressor complex.miRNAs in human cancer.MicroRNA-223-3p Regulates Ovarian Cancer Cell Proliferation and Invasion by Targeting SOX11 Expression.The tumour-suppressive miR-29a/b1 cluster is regulated by CEBPA and blocked in human AML.MiR-223 suppresses cell proliferation by targeting IGF-1R.miR-223 and miR-142 attenuate hematopoietic cell proliferation, and miR-223 positively regulates miR-142 through LMO2 isoforms and CEBP-β.Selective upregulation of microRNA expression in peripheral blood leukocytes in IL-10-/- mice precedes expression in the colon Effect of CpG island methylation on microRNA expression in the k-562 cell line.Leukaemogenesis: more than mutant genes Down-regulation of microRNAs 222/221 in acute myelogenous leukemia with deranged core-binding factor subunits Differential microRNA expression following infection with a mouse-adapted, highly virulent avian H5N2 virus.Evaluation of microRNA expression in patient bone marrow aspirate slides.MicroRNA-16 is down-regulated in mutated FLT3 expressing murine myeloid FDC-P1 cells and interacts with Pim-1.Complete characterization of the microRNAome in a patient with acute myeloid leukemia The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanoma A histone acetyltransferase p300 inhibitor C646 induces cell cycle arrest and apoptosis selectively in AML1-ETO-positive AML cells Advances in molecular genetics and treatment of core-binding factor acute myeloid leukemia RUNX1 repression-independent mechanisms of leukemogenesis by fusion genes CBFB-MYH11 and AML1-ETO (RUNX1-RUNX1T1).MicroRNA profiling in human neutrophils during bone marrow granulopoiesis and in vivo exudation.MicroRNAs and their applications in kidney diseases MicroRNA programs in normal and aberrant stem and progenitor cells.MiR-223 suppresses endometrial carcinoma cells proliferation by targeting IGF-1R

P2860

Q21134702-C85FC4E5-B1C5-46C9-8E0C-A17BB7D561D5 Q21198866-CC1A7DCB-3063-45D8-B50C-C0E7F1597C30 Q24628888-65DF17D3-25F4-42ED-A392-E2FFD709EBFB Q24633341-4FC0C9FE-3169-49DD-A5AE-96BC6FA2831C Q24644516-C0F6873E-6F5C-41A7-9109-9C6160FC16AA Q26775176-D770B3A9-ACA8-4DE9-9F78-5AC95A8BF3C7 Q26852479-06054CCD-E7CA-4B2E-9D6D-4E11B9CB36EC Q26995383-EC959926-277A-4FC9-BAA3-21A6784744E8 Q27003385-8C2613A6-9506-48EB-8683-06D20BBD958E Q27013740-67FFF1DB-8C96-485E-A928-2986A3C0CA68 Q27693865-5C6C2CDE-D3FB-46A9-9924-6B5A72CFA8F7 Q28283112-4D0F4236-BF7B-4ED0-9AFD-26863EB872D3 Q28285049-95BF9EF4-CA33-4585-8B05-94F2ED9D5A9D Q28486136-831BAE85-2734-40E5-80A1-B632BCF7EF40 Q30528539-A067C0E8-6CBF-4393-BF72-0CC8BB36AA85 Q33379264-E3FE4EF1-BEC3-4DE8-B242-736B0BEF11CC Q33653403-2BAFA1A2-D8A7-4308-90D7-BB2AE9C33C32 Q33786949-F9004E2A-96DC-4135-AB65-60614446A7CE Q33815742-39C3E6B1-AA52-497E-AC53-D245ADBDE225 Q33827750-8A831F41-D07E-4AB3-8ACB-06CA553575FD Q33838718-0C836F1A-BE43-4A8B-9C7F-3C664510C893 Q34005915-2A2F3E6C-AD39-48CA-813B-D3AEED93B94B Q34071730-0FD0FD90-9093-4203-A62A-1ED16E11783F Q34139102-6BDA0E4A-3F9F-4B7F-92BA-1AC238D0C8FC Q34229305-996DA212-E6B1-4A7B-9008-D1C28D5BAC7C Q34233240-8C09DB29-81FA-46FF-A169-EE8A9B2F8176 Q34275371-A400CC2F-042F-4FEB-9224-8120D76BE1EC Q34300594-F219AEDF-07E2-4D94-9967-FF56F49338E2 Q34306292-4089EC42-6F34-4740-8C0C-A811830818C9 Q34389101-B6D0C7EC-28AA-4541-AD2C-6BBCE8E3F5CB Q34412520-094B3F9F-40B5-4D60-83FA-0E7C8CC87366 Q34450485-0ED11C24-BD68-4FB5-BA52-071287A93A72 Q34459058-AB5BE1BE-8529-4CD0-BA0F-149DFF118E3A Q34580082-88442DC3-9ED6-49EF-B3DE-36A0431D2804 Q34598109-BAD92AC2-E461-4455-8409-19C5BCC7A36A Q34621037-07DDE31B-AD93-42F2-B98E-F04A04782348 Q34648024-E9E25D47-A0FC-4690-A168-FF295E8A448B Q34696427-6CD9363F-8085-4753-B206-7969A0908139 Q34867995-02D37970-1E2D-44E0-995A-2AE94CA816A2 Q34978831-56E6E632-F8EB-475D-894A-AD07D7A8C22B

P2860

Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein.

http://www.wikidata.org/entity/Q34712578

description

2007 nî lūn-bûn

@nan

2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Epigenetic silencing of the my ...... 3 by the AML1/ETO oncoprotein.

@ast

Epigenetic silencing of the my ...... 3 by the AML1/ETO oncoprotein.

@en

Epigenetic silencing of the my ...... 3 by the AML1/ETO oncoprotein.

@nl

type

label

Epigenetic silencing of the my ...... 3 by the AML1/ETO oncoprotein.

@ast

Epigenetic silencing of the my ...... 3 by the AML1/ETO oncoprotein.

@en

Epigenetic silencing of the my ...... 3 by the AML1/ETO oncoprotein.

@nl

prefLabel

Epigenetic silencing of the my ...... 3 by the AML1/ETO oncoprotein.

@ast

Epigenetic silencing of the my ...... 3 by the AML1/ETO oncoprotein.

@en

Epigenetic silencing of the my ...... 3 by the AML1/ETO oncoprotein.

@nl

P1433

Q34712578-04C60AAE-5087-4491-98E5-696BCF1E4260

P1476

Q34712578-1434F460-4078-48BB-9EC1-BA17DEC4E2EE

P2093

Q34712578-41C5642E-0B94-4CEA-B56A-8C723E6BC451

Q34712578-669FE15A-198B-4701-A932-119E9F4FD476

Q34712578-728150B2-D277-4591-8D9A-9E5241C381D5

Q34712578-8919CE42-A436-42AC-98D4-75FB81781FD9

Q34712578-A0BA6C95-8867-416A-ACD8-232E03F8B01D

Q34712578-AA11F549-1E46-4644-B7F7-F27BBA647194

Q34712578-B7997C4B-B3FD-4073-88CA-49D940EEBEEF

Q34712578-C7751A44-4073-4F33-AE6D-8CFCD7C068FE

P304

Q34712578-3A843938-7802-4BC5-AE3E-5E0307115D7A

P31

Q34712578-FDB97A57-6C04-478F-B4F8-BC0E5734F5BA

P356

Q34712578-1C729821-A5F6-47F6-9073-7B3FC876FC31

P433

Q34712578-770D2D4D-5F60-4C76-9C6B-3D62CC03E5A4

P478

Q34712578-1E8BC391-6EE5-41B0-8734-D46774D8B613

P50

Q34712578-2DCDE1CC-25FE-4F49-8FF9-42F211A5062F

Q34712578-6FF6D2CB-2FA3-4698-9C71-EDD7A495C127

Q34712578-90C73AB5-AC4F-449D-A9B0-5BA72F636BCC

Q34712578-D25D85C6-3C98-49CC-A7D9-4065CF5AA7DE

P577

Q34712578-134136DF-365C-4FC5-AFFD-DFB7C972279E

P5875

Q34712578-BBCF9FA5-99AA-4B9E-8995-C33F0F64AECF

P698

Q34712578-0FEAAD6D-052A-4A50-BE84-BC1CDD182B85

P921

Q34712578-87141FFF-F83D-4B07-B61B-7641C7DCE560

P356

J.CCR.2007.09.020

P1433

P1476

Epigenetic silencing of the my ...... 23 by the AML1/ETO oncoprotein

@en

P2093

Daniela Diverio

http://www.w3.org/2001/XMLSchema#string

Emanuele Ammatuna

http://www.w3.org/2001/XMLSchema#string

Francesco Grignani

http://www.w3.org/2001/XMLSchema#string

Francesco Lo-Coco

http://www.w3.org/2001/XMLSchema#string

Giuseppe Zardo

http://www.w3.org/2001/XMLSchema#string

Linda M Starnes

http://www.w3.org/2001/XMLSchema#string

Marco Mancini

http://www.w3.org/2001/XMLSchema#string

Serena Racanicchi

http://www.w3.org/2001/XMLSchema#string

P304

457-466

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CCR.2007.09.020

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Lorena Travaglini

Giuseppe Cimino

P577

2007-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5849574

http://www.w3.org/2001/XMLSchema#string

P698

17996649

http://www.w3.org/2001/XMLSchema#string

P921